-
Tytuł:
-
Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
-
Autorzy:
-
Afaneh H; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Straif-Bourgeois S; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Oral E; Department of Biostatistics, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Wennerstrom A; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Sugarman O; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Robinson WT; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
Whittington A; University of Louisiana at Monroe, Medicaid, Monroe, Lousiana, United States of America.
Trapido E; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
-
Źródło:
-
PloS one [PLoS One] 2021 Oct 06; Vol. 16 (10), pp. e0257437. Date of Electronic Publication: 2021 Oct 06 (Print Publication: 2021).
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: San Francisco, CA : Public Library of Science
-
MeSH Terms:
-
Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Cross-Sectional Studies ; Health Services Accessibility ; Hepacivirus/drug effects ; Humans ; Louisiana/epidemiology ; Medicaid ; New Orleans/epidemiology ; United States/epidemiology
-
References:
-
JAMA. 2018 Nov 20;320(19):1977-1978. (PMID: 30383176)
BMC Med. 2017 Nov 20;15(1):204. (PMID: 29151365)
AIDS Care. 2015;27(7):829-35. (PMID: 25814041)
Pharmacol Ther. 2018 Mar;183:118-126. (PMID: 29024739)
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17. (PMID: 32271723)
Liver Int. 2018 Feb;38 Suppl 1:7-13. (PMID: 29427484)
Acta Biomed. 2018 Oct 08;89(3):321-331. (PMID: 30333452)
-
Substance Nomenclature:
-
0 (Antiviral Agents)
-
Entry Date(s):
-
Date Created: 20211006 Date Completed: 20211124 Latest Revision: 20211124
-
Update Code:
-
20240104
-
PubMed Central ID:
-
PMC8494345
-
DOI:
-
10.1371/journal.pone.0257437
-
PMID:
-
34613969
-
Introduction: This article presents the Louisiana Hepatitis C Elimination Program's evaluation protocol underway at the Louisiana State University Health Sciences Center-New Orleans. With the availability of direct-acting antiviral (DAA) agents, the elimination of Hepatitis C (HCV) has become a possibility. The HCV Elimination Program was initiated by the Louisiana Department of Health (LDH) Office of Public Health (OPH), LDH Bureau of Health Services Financing (Medicaid), and the Louisiana Department of Public Safety and Corrections (DPSC) to provide HCV treatment through an innovative pricing arrangement with Asegua Therapeutics, whereby a fixed cost is set for a supply of treatment over five years.
Materials and Methods: A cross-sectional study design will be used. Data will be gathered from two sources: 1) an online survey administered via REDCap to a sample of Medicaid members who are receiving HCV treatment, and 2) a de-identified data set that includes both Medicaid claims data and OPH surveillance data procured via a Data Use Agreement between LSUHSC-NO and Louisiana Medicaid.
Discussion: The evaluation will contribute to an understanding of the scope and reach of this innovative treatment model, and as a result, an understanding of areas for improvement. Further, this evaluation may provide insight for other states considering similar contracting mechanisms and programs.
Competing Interests: The authors have declared that no competing interests exist.